{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:15:31Z","timestamp":1784211331638,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00393-021-00962-z","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T12:03:17Z","timestamp":1614340997000},"page":"243-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Verordnung von Schmerzmitteln bei Patienten mit rheumatischen Erkrankungen in Deutschland","Prescription of analgesics in patients with rheumatic diseases in Germany"],"prefix":"10.1007","volume":"80","author":[{"given":"K.","family":"Albrecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Callhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"issue":"1","key":"962_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s00393-016-0156-5","volume":"76","author":"K Albrecht","year":"2017","unstructured":"Albrecht\u00a0K, Huscher\u00a0D, Eidner\u00a0T, Kleinert\u00a0S, Spathling-Mestekemper\u00a0S, Bischoff\u00a0S, Zink\u00a0A (2017) Medical treatment of rheumatoid arthritis in 2014: current data from the German collaborative arthritis centers. Z\u00a0Rheumatol 76(1):50\u201357. https:\/\/doi.org\/10.1007\/s00393-016-0156-5","journal-title":"Z Rheumatol"},{"issue":"2","key":"962_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00393-017-0294-4","volume":"77","author":"K Albrecht","year":"2018","unstructured":"Albrecht\u00a0K, Luque Ramos\u00a0A, Callhoff\u00a0J, Hoffmann\u00a0F, Minden\u00a0K, Zink\u00a0A (2018) Outpatient care and disease burden of rheumatoid arthritis : results of a\u00a0linkage of claims data and a\u00a0survey of insured persons. Z\u00a0Rheumatol 77(2):102\u2013112. https:\/\/doi.org\/10.1007\/s00393-017-0294-4","journal-title":"Z Rheumatol"},{"issue":"1","key":"962_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00393-020-00775-6","volume":"79","author":"M Schneider","year":"2020","unstructured":"Schneider\u00a0M, Baseler\u00a0G, Funken\u00a0O, Heberger\u00a0S, Kiltz\u00a0U, Klose\u00a0P, Kruger\u00a0K, Langhorst\u00a0J, Mau\u00a0W, Oltman\u00a0R, Richter\u00a0B, Seitz\u00a0S, Sewerin\u00a0P, Tholen\u00a0R, Weseloh\u00a0C, Witthoft\u00a0M, Specker\u00a0C (2020) Management of early rheumatoid arthritis : interdisciplinary guideline. Z\u00a0Rheumatol 79(1):1\u201338. https:\/\/doi.org\/10.1007\/s00393-020-00775-6","journal-title":"Z Rheumatol"},{"issue":"1","key":"962_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00393-019-00707-z","volume":"79","author":"U Kiltz","year":"2020","unstructured":"Kiltz\u00a0U, Braun\u00a0J (2020) Current treatment of axial spondylarthritis : clinical efficacy. Z\u00a0Rheumatol 79(1):13\u201322. https:\/\/doi.org\/10.1007\/s00393-019-00707-z","journal-title":"Z Rheumatol"},{"issue":"2","key":"962_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41584-019-0360-1","volume":"16","author":"SC Kim","year":"2020","unstructured":"Kim\u00a0SC, Solomon\u00a0DH (2020) Towards defining the safer use of opioids in rheumatology. Nat Rev Rheumatol 16(2):71\u201372. https:\/\/doi.org\/10.1038\/s41584-019-0360-1","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"962_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3899\/jrheum.180668","volume":"46","author":"A Luque Ramos","year":"2019","unstructured":"Luque Ramos\u00a0A, Redeker\u00a0I, Hoffmann\u00a0F, Callhoff\u00a0J, Zink\u00a0A, Albrecht\u00a0K (2019) Comorbidities in patients with rheumatoid arthritis and their association with patient-reported outcomes: results of claims data linked to questionnaire survey. J\u00a0Rheumatol 46(6):564\u2013571. https:\/\/doi.org\/10.3899\/jrheum.180668","journal-title":"J Rheumatol"},{"key":"962_CR7","unstructured":"Gelbe Liste (2018) WHO-Stufenplan. https:\/\/www.gelbe-liste.de\/schmerztherapie\/schmerztherapie-who-stufenplan. Zugegriffen: 9. Sept. 2020"},{"key":"962_CR8","doi-asserted-by":"publisher","unstructured":"Pace MLG, Glickman M, Grande E, Zupanic T, Wojtyniak B et\u00a0al (2013) Revision of the European standard population report of Eurostat\u2019s task force. Eurostat, European Union. https:\/\/ec.europa.eu\/eurostat\/web\/products-manuals-and-guidelines\/-\/KS-RA-13-028. Zugegriffen: 22. Sept. 2020. https:\/\/doi.org\/10.2785\/11470","DOI":"10.2785\/11470"},{"issue":"5","key":"962_CR9","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/ejp.802","volume":"20","author":"U Marschall","year":"2016","unstructured":"Marschall\u00a0U, L\u2019Hoest\u00a0H, Radbruch\u00a0L, Hauser\u00a0W (2016) Long-term opioid therapy for chronic non-cancer pain in Germany. Eur J Pain 20(5):767\u2013776. https:\/\/doi.org\/10.1002\/ejp.802","journal-title":"Eur J Pain"},{"issue":"3","key":"962_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00393-013-1244-4","volume":"73","author":"F Luttosch","year":"2014","unstructured":"Luttosch\u00a0F, Baerwald\u00a0C (2014) Pain management in elderly patients. Z\u00a0Rheumatol 73(3):233\u2013243. https:\/\/doi.org\/10.1007\/s00393-013-1244-4","journal-title":"Z Rheumatol"},{"issue":"3","key":"962_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00482-015-0003-7","volume":"29","author":"J Schulze","year":"2015","unstructured":"Schulze\u00a0J, Freitag\u00a0MH, Glaeske\u00a0G, Schmiemann\u00a0G, Hoffmann\u00a0F (2015) Pain medication in nursing home residents with and without cancer. Most frequently with metamizole. Schmerz 29(3):276\u2013284. https:\/\/doi.org\/10.1007\/s00482-015-0003-7","journal-title":"Schmerz"},{"key":"962_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2318-14-20","volume":"14","author":"F Hoffmann","year":"2014","unstructured":"Hoffmann\u00a0F, van den Bussche\u00a0H, Wiese\u00a0B, Glaeske\u00a0G, Kaduszkiewicz\u00a0H (2014) Diagnoses indicating pain and analgesic drug prescription in patients with dementia: a\u00a0comparison to age- and sex-matched controls. BMC Geriatr 14:20. https:\/\/doi.org\/10.1186\/1471-2318-14-20","journal-title":"BMC Geriatr"},{"issue":"5","key":"962_CR13","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/art.40789","volume":"71","author":"YC Lee","year":"2019","unstructured":"Lee\u00a0YC, Kremer\u00a0J, Guan\u00a0H, Greenberg\u00a0J, Solomon\u00a0DH (2019) Chronic opioid use in rheumatoid arthritis: prevalence and predictors. Arthritis Rheumatol 71(5):670\u2013677. https:\/\/doi.org\/10.1002\/art.40789","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"962_CR14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s10067-016-3239-4","volume":"35","author":"JA Zamora-Legoff","year":"2016","unstructured":"Zamora-Legoff\u00a0JA, Achenbach\u00a0SJ, Crowson\u00a0CS, Krause\u00a0ML, Davis\u00a0JM 3rd, Matteson\u00a0EL (2016) Opioid use in patients with rheumatoid arthritis 2005\u20132014: a\u00a0population-based comparative study. Clin Rheumatol 35(5):1137\u20131144. https:\/\/doi.org\/10.1007\/s10067-016-3239-4","journal-title":"Clin Rheumatol"},{"issue":"9","key":"962_CR15","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/art.40152","volume":"69","author":"JR Curtis","year":"2017","unstructured":"Curtis\u00a0JR, Xie\u00a0F, Smith\u00a0C, Saag\u00a0KG, Chen\u00a0L, Beukelman\u00a0T, Mannion\u00a0M, Yun\u00a0H, Kertesz\u00a0S (2017) Changing trends in opioid use among patients with rheumatoid arthritis in the United States. Arthritis Rheumatol 69(9):1733\u20131740. https:\/\/doi.org\/10.1002\/art.40152","journal-title":"Arthritis Rheumatol"},{"key":"962_CR16","doi-asserted-by":"publisher","first-page":"3891436","DOI":"10.1155\/2020\/3891436","volume":"2020","author":"ME Machado-Duque","year":"2020","unstructured":"Machado-Duque\u00a0ME, Ramirez-Valencia\u00a0DM, Murillo-Munoz\u00a0MM, Machado-Alba\u00a0JE (2020) Trends in opioid use in a\u00a0cohort of patients with rheumatoid arthritis. Pain Res Manag 2020:3891436. https:\/\/doi.org\/10.1155\/2020\/3891436","journal-title":"Pain Res Manag"},{"issue":"2","key":"962_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S2215-0366(18)30471-1","volume":"6","author":"HJ Curtis","year":"2019","unstructured":"Curtis\u00a0HJ, Croker\u00a0R, Walker\u00a0AJ, Richards\u00a0GC, Quinlan\u00a0J, Goldacre\u00a0B (2019) Opioid prescribing trends and geographical variation in England, 1998\u20132018: a\u00a0retrospective database study. Lancet Psychiatry 6(2):140\u2013150. https:\/\/doi.org\/10.1016\/S2215-0366(18)30471-1","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"962_CR18","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ejp.1291","volume":"23","author":"C Chenaf","year":"2019","unstructured":"Chenaf\u00a0C, Kabore\u00a0JL, Delorme\u00a0J, Pereira\u00a0B, Mulliez\u00a0A, Zenut\u00a0M, Delage\u00a0N, Ardid\u00a0D, Eschalier\u00a0A, Authier\u00a0N (2019) Prescription opioid analgesic use in France: trends and impact on morbidity-mortality. Eur J Pain 23(1):124\u2013134. https:\/\/doi.org\/10.1002\/ejp.1291","journal-title":"Eur J Pain"},{"issue":"612","key":"962_CR19","first-page":"1262","volume":"14","author":"D Ruchat","year":"2018","unstructured":"Ruchat\u00a0D, Suter\u00a0MR, Rodondi\u00a0PY, Berna\u00a0C (2018) Opioid consumption from 1985 to 2015 : the situation in Switzerland, with an international comparison. Rev Med Suisse 14(612):1262\u20131266","journal-title":"Rev Med Suisse"},{"issue":"6","key":"962_CR20","doi-asserted-by":"publisher","first-page":"e019491","DOI":"10.1136\/bmjopen-2017-019491","volume":"8","author":"T Ashaye","year":"2018","unstructured":"Ashaye\u00a0T, Hounsome\u00a0N, Carnes\u00a0D, Taylor\u00a0SJC, Homer\u00a0K, Eldridge\u00a0S, Spencer\u00a0A, Rahman\u00a0A, Foell\u00a0J, Underwood\u00a0MR, Team\u00a0CS (2018) Opioid prescribing for chronic musculoskeletal pain in UK primary care: results from a\u00a0cohort analysis of the COPERS trial. BMJ Open 8(6):e19491. https:\/\/doi.org\/10.1136\/bmjopen-2017-019491","journal-title":"BMJ Open"},{"issue":"2","key":"962_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3899\/jrheum.170630","volume":"45","author":"JD Dau","year":"2018","unstructured":"Dau\u00a0JD, Lee\u00a0M, Ward\u00a0MM, Gensler\u00a0LS, Brown\u00a0MA, Learch\u00a0TJ, Diekman\u00a0LA, Tahanan\u00a0A, Rahbar\u00a0MH, Weisman\u00a0MH, Reveille\u00a0JD (2018) Opioid analgesic use in patients with ankylosing spondylitis: an analysis of the prospective study of outcomes in an ankylosing spondylitis cohort. J\u00a0Rheumatol 45(2):188\u2013194. https:\/\/doi.org\/10.3899\/jrheum.170630","journal-title":"J Rheumatol"},{"issue":"8","key":"962_CR22","doi-asserted-by":"publisher","first-page":"e0221153","DOI":"10.1371\/journal.pone.0221153","volume":"14","author":"B Rosner","year":"2019","unstructured":"Rosner\u00a0B, Neicun\u00a0J, Yang\u00a0JC, Roman-Urrestarazu\u00a0A (2019) Opioid prescription patterns in Germany and the global opioid epidemic: systematic review of available evidence. PLoS ONE 14(8):e221153. https:\/\/doi.org\/10.1371\/journal.pone.0221153","journal-title":"PLoS ONE"},{"issue":"2","key":"962_CR23","doi-asserted-by":"publisher","first-page":"e001029","DOI":"10.1136\/rmdopen-2019-001029","volume":"5","author":"AP Trouvin","year":"2019","unstructured":"Trouvin\u00a0AP, Berenbaum\u00a0F, Perrot\u00a0S (2019) The opioid epidemic: helping rheumatologists prevent a\u00a0crisis. RMD Open 5(2):e1029. https:\/\/doi.org\/10.1136\/rmdopen-2019-001029","journal-title":"RMD Open"},{"issue":"2","key":"962_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s00393-015-1686-y","volume":"75","author":"M Krasselt","year":"2016","unstructured":"Krasselt\u00a0M, Hauser\u00a0W, Petzke\u00a0F, Baerwald\u00a0C (2016) S3 guidelines on long-term opioid treatment in non-cancer pain. Recommendations for opioid use in clinical rheumatology. Z\u00a0Rheumatol 75(2):128\u2013132. https:\/\/doi.org\/10.1007\/s00393-015-1686-y","journal-title":"Z Rheumatol"},{"issue":"1","key":"962_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00393-015-0018-6","volume":"75","author":"WW Bolten","year":"2016","unstructured":"Bolten\u00a0WW, Kruger\u00a0K, Reiter-Niesert\u00a0S, Stichtenoth\u00a0DO, Kommission Pharmakotherapie der DGRh (2016) DGRh recommendations for the implementation of current security aspects in the NSAID treatment of musculoskeletal pain. Z\u00a0Rheumatol 75(1):103\u2013116. https:\/\/doi.org\/10.1007\/s00393-015-0018-6","journal-title":"Z Rheumatol"},{"issue":"6","key":"962_CR26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00393-016-0148-5","volume":"75","author":"WW Bolten","year":"2016","unstructured":"Bolten\u00a0WW, Kruger\u00a0K (2016) Coxibs. Z\u00a0Rheumatol 75(6):595\u2013598. https:\/\/doi.org\/10.1007\/s00393-016-0148-5","journal-title":"Z Rheumatol"},{"issue":"7","key":"962_CR27","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/pds.4202","volume":"26","author":"K Jobski","year":"2017","unstructured":"Jobski\u00a0K, Luque Ramos\u00a0A, Albrecht\u00a0K, Hoffmann\u00a0F (2017) Pain, depressive symptoms and medication in German patients with rheumatoid arthritis-results from the linking patient-reported outcomes with claims data for health services research in rheumatology (PROCLAIR) study. Pharmacoepidemiol Drug Saf 26(7):766\u2013774. https:\/\/doi.org\/10.1002\/pds.4202","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"962_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00393-019-0650-7","volume":"78","author":"H Haibel","year":"2019","unstructured":"Haibel\u00a0H, Redeker\u00a0I, Zink\u00a0A, Callhoff\u00a0J, Marschall\u00a0U, Hoffmann\u00a0F, Sieper\u00a0J, Poddubnyy\u00a0D (2019) Health care and disease burden in persons with axial spondyloarthritis in Germany. Z\u00a0Rheumatol 78(9):865\u2013874. https:\/\/doi.org\/10.1007\/s00393-019-0650-7","journal-title":"Z Rheumatol"},{"issue":"7","key":"962_CR29","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1136\/annrheumdis-2017-212629","volume":"77","author":"I Redeker","year":"2018","unstructured":"Redeker\u00a0I, Hoffmann\u00a0F, Callhoff\u00a0J, Haibel\u00a0H, Sieper\u00a0J, Zink\u00a0A, Poddubnyy\u00a0D (2018) Determinants of psychological well-being in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data. Ann Rheum Dis 77(7):1017\u20131024. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212629","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"962_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00393-019-0680-1","volume":"78","author":"K Albrecht","year":"2019","unstructured":"Albrecht\u00a0K, Callhoff\u00a0J, Zink\u00a0A (2019) Long-term trends in rheumatology care : achievements and deficits in 25\u00a0years of the German national rheumatology database. Z\u00a0Rheumatol 78(2):65\u201372. https:\/\/doi.org\/10.1007\/s00393-019-0680-1","journal-title":"Z Rheumatol"},{"issue":"1","key":"962_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00393-019-0678-8","volume":"79","author":"I Redeker","year":"2020","unstructured":"Redeker\u00a0I, Callhoff\u00a0J, Hoffmann\u00a0F, Saam\u00a0J, Haibel\u00a0H, Sieper\u00a0J, Zink\u00a0A, Poddubnyy\u00a0D (2020) Cost of illness in axial spondylarthritis for patients with and without tumor necrosis factor inhibitor treatment: results of a\u00a0routine data analysis. Z\u00a0Rheumatol 79(1):85\u201394. https:\/\/doi.org\/10.1007\/s00393-019-0678-8","journal-title":"Z Rheumatol"},{"key":"962_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2020.1762923","author":"K Rebane","year":"2020","unstructured":"Rebane\u00a0K, Aalto\u00a0K, Haanpaa\u00a0M, Puolakka\u00a0K, Virta\u00a0LJ, Kautiainen\u00a0H, Pohjankoski\u00a0H (2020) Initiating disease-modifying anti-rheumatic drugs rapidly reduces purchases of analgesic drugs in juvenile idiopathic arthritis. Scand J Rheumatol. https:\/\/doi.org\/10.1080\/03009742.2020.1762923","journal-title":"Scand J Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-021-00962-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-021-00962-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-021-00962-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T12:07:27Z","timestamp":1617106047000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-021-00962-z"}},"subtitle":["Eine Analyse von Abrechnungsdaten","A\u00a0claims data analysis. German version"],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["962"],"URL":"https:\/\/doi.org\/10.1007\/s00393-021-00962-z","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,26]]},"assertion":[{"value":"12 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.\u00a0Albrecht, U.\u00a0Marschall und J.\u00a0Callhoff geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}